Bovine viral vaccines, diagnostics, and eradication: Past, present, and future

Advances in Veterinary Medicine

Volumn 41, Issue C, 1999, Pages 197-216

  Van Oirschot, Jan T ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; CATTLE; CATTLE DISEASE; FOOT AND MOUTH DISEASE; IMMUNOLOGY; REVIEW; VACCINATION; VIRUS INFECTION;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CATTLE DISEASES; FOOT-AND-MOUTH DISEASE; INFECTIOUS BOVINE RHINOTRACHEITIS; VACCINATION; VIRAL VACCINES; VIRUS DISEASES;

EID: 0032608245     PISSN: 1093975X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3519(99)80017-2     Document Type: Chapter

References (82)

1. Barber D.M.L., and Nettleton P.F. Investigations into bovine viral diarrhoea virus in a dairy herd. Vet. Rec. 133 (1993) 549-550
2. Beck E., and Strohmaier K. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J. Virol. 61 (1987) 1621-1629
3. Berger H.-G., Straub O.C., Ahl R., Tesar M., and Marquardt O. Identification of foot-and-mouth disease virus replication in vaccinated cattle by antibodies to nonstructural virus proteins. Vaccine 8 (1990) 213-216
4. Bergmann I.E., De Mello P.A., Neitzert E., Beck E., and Gomes I. Diagnosis of persistent aphtovirus infection and its differentiation from vaccination response in cattle by use of enzyme-linked immunoelectrotransfer blot analysis with bioengineered nonstructural viral antigens. Am. J. Vet. Res. 54 (1993) 825-831
5. Bitsch V., and Roensholt L. Control of bovine viral diarrhea virus infection without vaccines. Vet. Clin. North Am. 11 (1995) 627-640
6. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., and Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1982) 30-33
7. Bolin S.R., and Ridpath J.F. Glycoprotein E2 of bovine viral dairrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease. Arch. Virol. 141 (1996) 1463-1477
8. Bosch J.C., Kaashoek M.J., Kroese A.H., and van Oirschot J.T. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet. Microbiol. 52 (1996) 223-234
9. Bosch J.C., De Jong M.C.M., Van Bree J., and van Oirschot J.T. Quantification of transmission of bovine herpesvirus 1 in cattle vaccinated with marker vacines. In: Bosch J.C. (Ed). Ph.D. Thesis (1997), Utrecht University 53-66
10. Bosch J.C., Kaashoek M.J., and van Oirschot J.T. Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. Vaccine 15 (1997) 1512-1517
11. Bosch J.C., De Jong M.C.M., Franken P., Frankena K., Hage J.J., Kaashoek M.J., Maris-Veldhuis M.A., Noordhuizen J.P.T.M., Van der Poel W.H.M., Verhoeff J., Weerdmeester K., Zimmer G.M., and van Oirschot J.T. An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. Vaccine 16 (1998) 265-271
12. Bosch J.C., Frankena K., and van Oirschot J.T. Effect on milk production of vaccination with a bovine herpesvirus 1 gene-deleted vaccine. Vet. Rec. 140 (1997) 196-199
13. Brock K.V., and Grooms D.L. Evaluation of a modified-live bovine viral diarrhoea virus vaccine by fetal challenge. Proc. European Society for Veterinary Virology Symp. Pestivirus Infect., 3rd. 1996, Lelystad, The Netherlands (1996) 177-179
14. Brown F. The development of chemically synthesized vaccines. Adv. Vet. Sci. Comp. Med. 33 (1989) 173-193
15. Brownlie J., Clarke M.C., Hooper L.B., and Bell G.D. Protection of bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet. Rec. 137 (1995) 58-62
16. Bruschke C.J.M., Moormann R.J.M., van Oirschot J.T., and Van Rijn P.A. A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine 15 (1997) 1940-1945
17. Bruschke C.J.M., van Oirschot J.T., and Van Rijn P.A. Two conventional inactivated BVDV vaccines do not prevent congenital infection. In preparation (1998)
18. Capstick P.B., Garland A.J.M., Chapman W.G., and Masters R.C. Production of foot-and-mouth disease virus antigen from BHK 21 clone 13 cells grown and infected in deep suspension cultures. Nature 205 (1965) 1135-1136
19. Carlsson U., Alenius S., and Sundquist B. Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes. Vaccine 9 (1991) 577-580
20. Clarke B.E., Newton S.E., Carroll A.R., Francis M.J., Appleyard G., Syred A.D., Highfield P.E., Rowlands D.J., and Brown F. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330 (1987) 381-384
21. Corapi W.V., French T.W., and Dubovi E.J. Severe thrombocytopenia in young calves experimentally infected with noncytopathic bovine viral diarrhea virus. J. Virol. 63 (1989) 3934-3943
22. Cortese V.S., West K., and Ellis J. Clinical and immunologic responses to type 2 BVDV challenge in vaccinated and unvaccinated calves. Proc. World Buiatrics Congr., 19th. Edinburgh, 1996 (1996) 610-613
23. Dekker A., Wensvoort G., and Terpstra C. Six antigenic groups within the genus pestivirus as identified by cross neutralization assays. Vet. Microbiol. 47 (1995) 317-329
24. Doel T.R., Williams L., and Barnett P.V. Emergency vaccination against foot-and-mouth disease: Rate of development of immunity and its implications of the carrier state. Vaccine 12 (1994) 592-600
25. Edwards S. The diagnosis of bovine virus diarrhoea-muscosal disease in cattle. Rev. Sci. Tech. Off. Int. Epizoot. 9 (1990) 115-130
26. Edwards S., and Gitao G.C. Highly sensitive antigen detection procedures for the diagnosis of infectious bovine rhinotracheitis: Amplifed ELISA and reverse passive haemagglutination. Vet. Microbiol. 13 (1987) 135-141
27. Entrican G., Dand A., and Nettleton P.F. A double monoclonal antibody ELISA for detecting pestivirus antigen in the blood of viraemic cattle and sheep. Vet. Microbiol. 43 (1995) 65-74
28. Flores E.F., Osorio F.A., Zanella E.L., Kit S., and Kit M. Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals. J. Vet. Diagn. Invest. 5 (1993) 534-540
29. Frankena K., Franken P., Vandehoek J., Koskamp G., and Kramps J.A. Probability of detecting antibodies to bovine herpesvirus 1 in bulk milk after the introduction of a positive animal on to a negative farm. Vet. Rec. 140 (1997) 90-92
30. Frenkel H.S. La culture du virus de la fièvre aphteuse sur l'epithelium de la langue des bovides. Bull. Off. Int. Epizoot. 28 (1947) 155-162
31. Harkness J.W., Roeder P.L., Drew T., Wood L., and Jeffrey M. The efficacy of an experimental inactivated BVD-MD vaccine. Proc. CEC Semin. Res. Anim. Husb. 1985 (1987) 233-250
32. Hartman A., Van Wuijckhuise L., Frankena K., Franken P., Wever P., De Wit J., and Kramps J. Within-herd BHV-1 prevalence prediction from an ELISA on bulk milk. Vet. Rec. 140 (1997) 484-485
33. Hofmann M.A., Brechtbühl K., and Stäuber N. Rapid characterization of new pestivirus strains by direct sequencing of PCR-amplified cDNA from the 5′ noncoding region. Arch. Virol. 139 (1994) 217-229
34. Holtz J.H., and Asher S.A. Polymerized colloidal crystal hydrogel films as intelligent chemical sensing materials. Nature 389 (1997) 829-832
35. Howard C.J., Clarke M.C., Sopp P., and Brownlie J. Systemic vaccination with inactivated bovine virus diarrhoea virus protects against respiratory challenge. Vet. Microbiol. 42 (1994) 171-179
36. Kaashoek M.J. Marker vaccines against bovine herpesvirus 1 infections. Ph.D. Thesis (1995), Utrecht University
37. Kaashoek M.J., and van Oirschot J.T. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine. Vet. Microbiol. 53 (1996) 191-197
38. Kaashoek M.J., Moerman A., Madic J., Rijsewijk F.A.M., Quak J., Gielkens A.L.J., and van Oirschot J.T. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12 (1994) 493
39. Kaashoek M.J., Moerman A., Madic J., Weerdmeester K., Maris-Veldhuis M., Rijsewijk F.A.M., and van Oirschot J.T. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 13 (1995) 342-346
40. Kaashoek M.J., Straver P.H., Van Rooij E.M.A., Quak J., and van Oirschot J.T. Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1. strains: clinical and virological aspects. Vet. Rec. 139 (1996) 416-421
41. Kaashoek M.J., Rijsewijk F.A.M., and van Oirschot J.T. Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection. Vet. Microbiol. 53 (1996) 103-110
42. Kaashoek M.J., Rijsewijk F.A.M., Ruuls R.C., Keil G.M., Thiry E., Pastoret P.-P., and van Oirschot J.T. Virulence, immunogenicity, and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or gI and gE gene. Vaccine 16 (1998) 802-809
43. Kit S. Genetically engineered pseudorabies and infectious bovine rhinotracheitis virus vaccine. Technological Advances in Vaccine Development (1988), Alan R. Liss, New York 183-195
44. Kit M., Kit S., Little S.P., DiMarchi R.D., and Gale C. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot and mouth disease epitopes. Vaccine 9 (1991) 564-572
45. Kleid D.G., Yansura D., Small B., Dowbenko D., Moore D.M., Grubman M.J., McKercher P.D., Morgan D.O., Robertson B.H., and Bachrach H.L. Cloned viral protein vaccine for foot-and-mouth disease: Responses in cattle and swine. Science 214 (1981) 1125-1129
46. Kowalski J., Gilbert S.A., Van Drunen Littel-Van den Hurk S., Van den Hurk J., Babiuk L.A., and Zamb T.J. Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine 11 (1993) 1100-1107
47. Kramps J.A., Magdalena J., Quak J., Weerdmeester K., Kaashoek M.J., Maris-Veldhuis M.A., Rijsewijk F.A.M., Keil G., and van Oirschot J.T. A simple, specific, and highly sensitive blocking enzyme-linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1. J. Clin. Microbiol. 32 (1994) 2175-2181
48. Kramps J.A., Perrin B., Edwards S., and van Oirschot J.T. A European interlaboratory trial to evaluate the reliability of serological diagnosis of bovine herpesvirus 1 infections. Vet. Microbiol. 53 (1996) 153-161
49. (in press). Kramps J.A., Van Maanen C.A., Van de Wetering G., Stienstra G., Quak J., Brinkhof J., Roensholt L., and Nylin B. A simple, rapid and reliable enzyme-linked immunosorbent assay for the detection of bovine virus diarrhoea virus (BVDV) specific antibodies in cattle serum, plasma and bulk milk. Vet. Microbiol. (1998)
50. Lin V.S.-Y., Motesharei K., Dancil K.-P.S., Sailor M.J., and Ghadiri M.R. A porous silicon-based optical interferometric biosensor. Science 278 (1997) 840-843
51. Mason P.W., Piccone M.E., McKenna T.St.-C., Chinsangaram J., and Grubman M.J. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227 (1997) 96-102
52. McClurkin A.W., Coria M.F., and Smith R.L. Evaluation of acetylethyleneimine-killed bovine viral diarrhea-mucosal disease virus (BVD) vaccine for prevention of BVD infection of the fetus. Proc. U.S. Anim. Health Assoc. 79 (1975) 114-123
53. Meyling A., Ronsholt L., Dalsgaard K., and Jensen A.M. Experimental exposure of vaccinated and non-vaccinated pregnant cattle to isolates of bovine viral diarrhoea virus (BVDV). Proc. CEC Semin. Res. Anim. Husb. 1985 (1987) 225-231
54. Moerman A., Straver P.J., De Jong M.C.M., Quak J., Baanvinger T., and van Oirschot J.T. A long term epidemiological study of bovine viral diarrhoea infections in a large herd of dairy cattle. Vet. Rec. 132 (1993) 622-626
55. Niskanen R. Relationship between levels of antibody to bovine viral diarrhoea virus in bulk tank milk and the prevalence of cows exposed to the virus. Vet. Rec. 133 (1993) 341-344
56. OIE Manual of Standards for Diagnostic Tests and Vaccines. 3rd ed. (1996), Office International des Epizooties, Paris
57. Paton D.J., Ibata G., Edwards S., and Wensvoort G. An ELISA detecting antibody to conserved pestivirus epitopes. J. Virol. Methods 31 (1991) 315-324
58. Pellerin C., Van den Hurk J., Lecomte J., and Tijssen P. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 203 (1994) 260-268
59. Perrin B., Bitsch V., Cordioli P., Edwards S., Eloit M., Guérin B., Lenihan P., Perrin M., Ronsholt L., van Oirschot J.T., Vanopdenbosch E., Wellemans G., Wizigmann G., and Thibier M. A European comparative study of serological methods for the diagnosis of infectious bovine rhinotracheitis. Rev. Sci. Tech. Off. Int. Epizoot. 12 (1993) 969-984
60. Perrin B., Calvo T., Cardioli P., Coudert M., Edwards S., Eloit M., Guérin B., Kramps J.A., Lenihan P., Paschaleri E., Perrin M., Schon J., van Oirschot J.T., Vanopdenbosch E., Wellemans G., Wizigmann G., and Thibier M. Selection of European Union standard reference sera for use in the serological diagnosis of infectious bovine rhinotracheitis. Rev. Sci. Tech. Off. Int. Epizoot. 13 (1994) 947-960
61. Rijsewijk F.A.M., Kaashoek M.J., Madic J., Paal H., Ruuls R., Gielkens A.L.J., and van Oirschot J.T. Characterization of a DNA rearrangement found in the unique short region of the Za strain of bovine herpesvirus type 1 and the vaccine properties of this strain. Proc. Int. Herpesvirus Workshop, 18th. Pittsburgh (1993) C-67
62. Rijsewijk F.A.M., Kaashoek M.J., Langeveld J.P.M., Meloen R.M., Judek J., Bienkowska-Szewczyk K., Maris-Veldhuis M.A., and van Oirschot J.T. Identification of epitopes on glycoprotein C of bovine herpesvirus 1 that allow differentiation between 'IBR-like' and 'IPV-like' strains. Proc. 22nd Int. Herpesvirus Workshop. San Diego, California, Aug. 2-8, 1997 (1997) 288
63. Schnurrenberger P.R., Sharman R.S., and Wise G.H. Attacking Animal Disease. Concepts and Strategies for Control and Eradication (1987), Iowa State University Press, Ames
64. Shannon A.D., Richards S.G., Kirkland P.D., and Moyle A. An antigen capture ELISA detects pestivirus antigens in blood and tissues of immunotolerant carrier cattle. J. Virol. Methods 34 (1991) 1-12
65. Straub O.C. Experiences with two BHV1 marker vaccines. Proc. World Buiatrics Congr., 19th. Edinburgh, 1996 (1996) 38-41
66. Strube W., Abar B., Bergle R.D., Block W., Heinen E., Kretzdorn D., Rodenbach C., and Schmeer N. Safety aspects in the development of an infectious bovine rhinotracheitis marker vaccine. Dev. Biol. Stand. 84 (1995) 75-81
67. Strube W., Auer S., Block W., Heinen E., Kretzdorn D., Rodenbach C., and Schmeer N. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs. Vet. Microbiol. 53 (1996) 181-189
68. Terpstra C., Van Maanen C., and Van Bekkum J.G. Endurance of immunity against foot-and-mouth disease in cattle after three consecutive annual vaccinations. Res. Vet. Sci. 49 (1990) 236-242
69. Van der Poel W.H.M., and Hage J.J. Onderzoek naar spreiding van een intramuscular toegediend levend gE-negatief BHV1 markervaccin op twee rundveebedrijven. Tijdschr. Diergeneeskd. 123 (1998) 109-111
70. van Drunen Littel-van den Hurk S., Tikoo S.K., Liang X., and Babiuk L.A. Bovine herpesvirus-1 vaccines. Immunol. Cell Biol. 71 (1993) 405-420
71. van Drunen Littel-van den Hurk S., Van Donkersgoed J., Kowalski J., Van den Hurk J.V., Harland R., Babiuk L.A., and Zamb T.J. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 12 (1994) 1295-1302
72. Van Engelenburg F.A.C., Maes R.K., van Oirschot J.T., and Rijsewijk F.A.M. Rapid and sensitive detection of bovine herpesvirus type 1 in bovine semen by a polymerase chain reaction based assay. J. Clin. Microbiol. 31 (1993) 3129-3135
73. van Oirschot J.T., Kaashoek M.J., Maris-Veldhuis M.A., Weerdmeester K., and Rijsewijk F.A.M. An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. J. Virol. Methods 67 (1997) 23-34
74. (in press). van Oirschot J.T., Bruschke C.J.M., and Van Rijn P.A. Vaccination of cattle against bovine viral diarrhoea. Vet. Microbiol. (1998)
75. Van Rijn P.A., Van Gennip H.G.P., Leendertse C.H., Bruschke C.J.M., Paton D.J., Moormann R.J.M., and van Oirschot J.T. Subdivision of the Pestivirus genus based on envelope glycoprotein E2. Virology 237 (1997) 337-348
76. Voges H. A non-viraemic AI bull persistently shedding BVDV in his semen-a previously unidentified source of infection. Proc. Eur. Symp. Control BVD Virus Cattle. Lillehammer, 1997 (1997) 45
77. von Forschner E., Bünger I., Küttler D., and Mehrkens L. IBR/IPV-Serodiagnostik mit ELISA-methoden an blut-, einzelmilch- und tankmilchproben; kontrollmassnahmen zur erhaltung unverdächtiger rinderherden sanierungswege unter berücksichtigung der impfung. Dtsch. Tieräerztl. Wochenschr. 93 (1986) 281-344
78. Waldmann O., Kobe Z., and Pyl G. Die aktive Immunisierung des Rindes gegen Maul-und Klauenseuche. Zentralbl. Bakteriol., Parasitenkd., Infektionskr. Hyg., Abt. I: Orig. 138 (1937) 401-412
79. Wellenberg G.J., Verstraten E.R.A.M., Mars M.H., and van Oirschot J.T. Detection of bovine herpesvirus 1 glycoprotein E antibodies in individual milk samples by enzyme-linked immunosorbent assays. J. Clin. Microbiol. 36 (1998) 909-913
80. Wellenberg G.J., Verstraten E.R.A.M., Mars M.H., and van Oirschot J.T. Detection of antibodies to glycoprotein E of bovine herpesvirus 1 in bulk samples by an ELISA. Vet. Rec. 192 (1998) 219-220
81. Wyler R., Engels M., and Schwyzer M. Infectious bovine rhinotracheitis/vulvovaginitis. In: Wittmann G. (Ed). Herpesvirus Diseases of Cattle, Horses and Pigs (1989), Kluwer Academic Publishers, Boston, Dordrecht, and London 1-72
82. Zimmer G.M., Wentink G.H., Brinkhof J., Bruschke C.J.M., Westenbrink F., Crauwels A.P.P., and De Goey I. Model for testing efficacy of bovine viral diarrhoea virus vaccines, against intrauterine infection. Proc. World Buiatrics Congr., 19th. Edinburgh, 1996 (1996) 217-220